Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/retatrutide-data-show-dramatic-weight-loss-other-benefits-2026a1000iz0?src=rss
Author :
Publish date : 2026-06-07 18:55:00
Copyright for syndicated content belongs to the linked Source.
